These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33290248)

  • 1. Postintervention Effects of Varying Treatment Arms on Glycemic Failure and β-Cell Function in the TODAY Trial.
    TODAY Study Group
    Diabetes Care; 2021 Jan; 44(1):75-80. PubMed ID: 33290248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY.
    TODAY Study Group
    Diabetes Care; 2013 Jun; 36(6):1749-57. PubMed ID: 23704674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial to maintain glycemic control in youth with type 2 diabetes.
    ; Zeitler P; Hirst K; Pyle L; Linder B; Copeland K; Arslanian S; Cuttler L; Nathan DM; Tollefsen S; Wilfley D; Kaufman F
    N Engl J Med; 2012 Jun; 366(24):2247-56. PubMed ID: 22540912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Hormone Mediators and Glycemic Control in Youths With Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.
    Lu C; Wolfs D; El Ghormli L; Levitsky LL; Levitt Katz LE; Laffel LM; Patti ME; Isganaitis E
    JAMA Netw Open; 2024 Feb; 7(2):e240447. PubMed ID: 38421647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Youth-onset type 2 diabetes mellitus: lessons learned from the TODAY study.
    Narasimhan S; Weinstock RS
    Mayo Clin Proc; 2014 Jun; 89(6):806-16. PubMed ID: 24702733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
    Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
    Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin, Insulin Sensitivity, β-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY.
    Arslanian S; El Ghormli L; Bacha F; Caprio S; Goland R; Haymond MW; Levitsky L; Nadeau KJ; White NH; Willi SM;
    Diabetes Care; 2017 Jan; 40(1):85-93. PubMed ID: 27803118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes.
    ; Zeitler P; Epstein L; Grey M; Hirst K; Kaufman F; Tamborlane W; Wilfley D
    Pediatr Diabetes; 2007 Apr; 8(2):74-87. PubMed ID: 17448130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.
    Bjornstad P; Nehus E; El Ghormli L; Bacha F; Libman IM; McKay S; Willi SM; Laffel L; Arslanian S; Nadeau KJ;
    Am J Kidney Dis; 2018 Jan; 71(1):65-74. PubMed ID: 29157731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of response to insulin therapy in youth with poorly-controlled type 2 diabetes in the TODAY trial.
    Bacha F; El Ghormli L; Arslanian S; Zeitler P; Laffel LM; Levitt Katz LE; Gandica R; Chang NT; Sprague JE; Macleish SA;
    Pediatr Diabetes; 2019 Nov; 20(7):871-879. PubMed ID: 31418516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.
    Fonseca V; Rosenstock J; Patwardhan R; Salzman A
    JAMA; 2000 Apr; 283(13):1695-702. PubMed ID: 10755495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of Medication Adherence in the TODAY Cohort of Youth With Type 2 Diabetes.
    Katz LL; Anderson BJ; McKay SV; Izquierdo R; Casey TL; Higgins LA; Wauters A; Hirst K; Nadeau KJ;
    Diabetes Care; 2016 Nov; 39(11):1956-1962. PubMed ID: 27352955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes.
    Zeitler P; Hirst K; Copeland KC; El Ghormli L; Levitt Katz L; Levitsky LL; Linder B; McGuigan P; White NH; Wilfley D;
    Diabetes Care; 2015 Dec; 38(12):2285-92. PubMed ID: 26537182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Monitoring of Blood Glucose in Youth-Onset Type 2 Diabetes: Results From the TODAY Study.
    Weinstock RS; Braffett BH; McGuigan P; Larkin ME; Grover NB; Walders-Abramson N; Laffel LM; Chan CL; Chang N; Schwartzman BE; Barajas RA; Celona-Jacobs N; Haymond MW;
    Diabetes Care; 2019 May; 42(5):903-909. PubMed ID: 30833375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menstrual Dysfunction in Girls From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.
    Kelsey MM; Braffett BH; Geffner ME; Levitsky LL; Caprio S; McKay SV; Shah R; Sprague JE; Arslanian SA;
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2309-2318. PubMed ID: 29697830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance.
    Retnakaran R; Qi Y; Harris SB; Hanley AJ; Zinman B
    Diabetes Care; 2011 Jul; 34(7):1601-4. PubMed ID: 21709296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta cell function and insulin sensitivity in obese youth with maturity onset diabetes of youth mutations vs type 2 diabetes in TODAY: Longitudinal observations and glycemic failure.
    Arslanian S; El Ghormli L; Haymond MH; Chan CL; Chernausek SD; Gandica RG; Gubitosi-Klug R; Levitsky LL; Siska M; Willi SM;
    Pediatr Diabetes; 2020 Jun; 21(4):575-585. PubMed ID: 32064729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.
    Viberti G; Kahn SE; Greene DA; Herman WH; Zinman B; Holman RR; Haffner SM; Levy D; Lachin JM; Berry RA; Heise MA; Jones NP; Freed MI
    Diabetes Care; 2002 Oct; 25(10):1737-43. PubMed ID: 12351470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents.
    Inge TH; Laffel LM; Jenkins TM; Marcus MD; Leibel NI; Brandt ML; Haymond M; Urbina EM; Dolan LM; Zeitler PS;
    JAMA Pediatr; 2018 May; 172(5):452-460. PubMed ID: 29532078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.
    Derosa G; Gaddi AV; Piccinni MN; Ciccarelli L; Salvadeo S; Peros E; Ghelfi M; Ferrari I; Cicero AF
    Pharmacotherapy; 2005 May; 25(5):637-45. PubMed ID: 15899724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.